Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 198 participants.
Also called NCT04907123
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 198 participants
- Sponsor
- Registry
-
NCT04907123
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT04907123. Randomized; single masking; primary purpose treatment. Start 2021-10 (anticipated); primary completion 2024-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial
- Acronym
- SERENA
- Condition
- Heart Failure
- Intervention (Other)
- Intensive sodiuria-guided diuretic treatment
- Intervention (Other)
- Standard diuretic treatment
- Lead sponsor
- University of Turin, Italy
Record details
- Record id
cardio:ct-nct04907123- Content hash
fd82b2f18019d2ebeaa839646a49cf6c06f50397b6a9fc95fd6b0b8652116204